<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: arial, helvetica, sans-serif">
<tr>
<td style="vertical-align: top; width: 25%"><p style="margin: 0; font-size: 9pt"><b><img alt="" src="lmrkx3x1.jpg"/><br/></b></p>
<p style="margin: 0; font-size: 9pt"><b> </b></p>
<p style="font: 10pt arial, helvetica, sans-serif; margin: 0pt 0; color: rgb(0,130,123)"><b>kenneth c. frazier</b></p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; color: #4d4d4d">chairman, president</p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; color: #4d4d4d">and chief executive officer</p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; color: #4d4d4d"> </p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; color: rgb(106,31,69)"><b>april 9, 2018</b></p>
</td>
<td style="width: 2%">    </td>
<td style="text-align: justify; width: 73%; vertical-align: top">
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; color: rgb(0,130,123); text-align: justify"><b>it is my pleasure
to invite you to the 2018 annual meeting of shareholders of merck &amp; co., inc. (“merck”, known as “msd”
outside the united states and canada), which will be held on tuesday, may 22, 2018, at 9:00 a.m., at the bridgewater marriott,
located at 700 commons way, bridgewater, new jersey 08807.</b></p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; color: rgb(0,130,123); text-align: justify"> </p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify">the attached notice of annual meeting of
shareholders and proxy statement will serve as your guide to the business to be conducted and provides details regarding admission
to the meeting.</p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify"> </p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify">for more than 125 years, merck has pursued
its mission to save and improve lives. each year provides great opportunity to further our mission and in 2017, merck took full
advantage of that opportunity to make its mark on the world.</p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify"> </p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify">our inventions, including keytruda and the
hope it is providing to a growing number of patients with different cancers, show that our innovation strategy is the right one
to create value for investors, patients and other stakeholders. we continue to invest significantly in research and development
and believe that is the pathway to deliver urgently needed medicines and vaccines to society, which is paramount to merck’s
long-term business success.</p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify"> </p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify">certainly, 2017 was a successful transitional
year for our organization as we demonstrated the underlying strength of our business and grew, despite the loss of exclusivity
of several products and other pressures.</p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify"> </p>
<p style="font: 9pt arial, helvetica, sans-serif; margin: 0pt 0; text-align: justify">this past year saw ongoing and significant
progress in our oncology business anchored by keytruda, but also lynparza, a parp inhibitor, which we gained access to through
a collaboration with astrazeneca, as well as a growing pipeline of early-stage oncology assets. in vaccines, there was</p></td></tr>
</table>